Photomedex, Inc. (NASDAQ and TASE:PHMD) received written notification (the “Notice”) from The NASDAQ Stock Market LLC (“NASDAQ”) that the Company has regained compliance with the minimum bid price requirements for continued listing on Nasdaq’s Capital Stock market. The Company’s common stock had traded at $1.00 per share or greater for the preceding 10 consecutive business days, from September 23 to October 6, 2016. In the letter, Nasdaq advised the Company that this matter is now closed.